Seeking Alpha

  Exelixis, Inc. - NASDAQ

10/21/2014, 6:52 PM ET
  • TruffelPig | Send Message 6 Jun 2012

    EXEL looks ready to move up on good news. NDA filed. Good phase III thyroid cancer data.
      EXEL vs. ETF Alternatives
      Company Description
      Exelixis Inc is a biotechnology company that develops small molecule therapies for the treatment of cancer.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States